Notably, the other antigens from the 6-molecule fingerprint, EpCAM, CD9, CD44, and CD59, showed a similar trend in expression change as that previously observed in preclinical models of docetaxel resistance and primary PCa patient samples (Supplementary Fig. S7B). The gene discussed is CD44; the disease is posterior cortical atrophy.